Clinical trial
Explore Plasma Biomarkers and Platelet Morphological Signatures for Predicting Prognosis in Patients With Extracorporeal CardioPulmonary Resuscitation (ECPR) Using Multi-omics and Platelet Morphology Analysis
NCT07113769 is registered in ClinicalTrials.gov with Central China Fuwai Hospital of Zhengzhou University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Explore Plasma Biomarkers and Platelet Morphological Signatures for Predicting Prognosis in Patients With Extracorporeal CardioPulmonary Resuscitation (ECPR) Using Multi-omics and Platelet Morphology Analysis
- Lead sponsor
- Central China Fuwai Hospital of Zhengzhou University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2025
- Completion date
- December 30, 2026
- Enrollment
- 130 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac arrest, extracorporeal membrane oxygenation (ecmo)